5/9
12:48 pm
vrdn
Rating for VRDN
Low
Report
Rating for VRDN
5/9
12:48 pm
vrdn
Rating for VRDN
Low
Report
Rating for VRDN
5/9
12:12 pm
vrdn
Rating for VRDN
Low
Report
Rating for VRDN
5/9
08:18 am
vrdn
Viridian Therapeutics, Inc. (NASDAQ: VRDN) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $30.00 price target on the stock.
Medium
Report
Viridian Therapeutics, Inc. (NASDAQ: VRDN) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $30.00 price target on the stock.
5/9
07:03 am
vrdn
Viridian Therapeutics, Inc. (NASDAQ: VRDN) was downgraded by analysts at B. Riley from a "buy" rating to a "neutral" rating. They now have a $20.00 price target on the stock, down previously from $25.00.
Medium
Report
Viridian Therapeutics, Inc. (NASDAQ: VRDN) was downgraded by analysts at B. Riley from a "buy" rating to a "neutral" rating. They now have a $20.00 price target on the stock, down previously from $25.00.
5/9
07:03 am
vrdn
Viridian Therapeutics, Inc. (NASDAQ: VRDN) was downgraded by analysts at B. Riley from a "buy" rating to a "neutral" rating. They now have a $20.00 price target on the stock, down previously from $25.00.
Medium
Report
Viridian Therapeutics, Inc. (NASDAQ: VRDN) was downgraded by analysts at B. Riley from a "buy" rating to a "neutral" rating. They now have a $20.00 price target on the stock, down previously from $25.00.
5/9
05:27 am
vrdn
Rating for VRDN
Medium
Report
Rating for VRDN
5/9
05:27 am
vrdn
Rating for VRDN
Medium
Report
Rating for VRDN
3/20
01:34 pm
vrdn
Viridian Therapeutics, Inc. (NASDAQ: VRDN) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $30.00 price target on the stock.
Low
Report
Viridian Therapeutics, Inc. (NASDAQ: VRDN) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $30.00 price target on the stock.
3/20
01:06 pm
vrdn
Rating for VRDN
Medium
Report
Rating for VRDN
3/20
01:06 pm
vrdn
Rating for VRDN
Medium
Report
Rating for VRDN